Anonymous
Guest
Anonymous
Guest
After all the shareholder value he has built at DNDN and SVNT, and the phenomenal commercial success he has led, you gotta know every big pharma out there is dying to have him as next CEO
Stay tune for August 16th. I bet something good is going to happen.
Stay tune for August 16th. I bet something good is going to happen.
Yeah, August 16th! The final, and certainly temporary, stock price jump Dendreon ever sees, resultant from better-than-expected Q2 results being reported, at which time they'll immediately dilute the stock 30% to raise cash in an attempt to make it last until the FANTASY that is automation can be realized. Assuming that also isn't delayed (don't worry, it will be).
And how did Q2 results outperform expectations? Simple. It was a one-time event, resultant from the artificially manufactured demand created by management through its limiting of the available manufacturing slots in Q4'13 and Q1'14 to create a tidal wave of infusions in Q2 in a last ditch effort to sell the company. Which, like everything else management does, won't work out.
DEAD MAN WALKING DNDN hits the ol' tombs by January, and the only arse holes getting paid will be SP, JE, and the Dan-da Bear. Nobody else makes out of here folks. They'll lie right to our faces...hell, the CEO JUST DID! Health issues...RIGHT.